SCHEMBL20122387

SCHEMBL20122387

CCC(=O)OCOC(=O)SC[C@H](NC(=O)C(C)(C)SC(=O)OCOC(=O)CC)C(=O)OCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ABCC3 O15438 1/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ ABCB11 O95342 1/20 0.37
▸ NR3C1 P04150 1/20 0.37
▸ RARG P13631 1/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ NR1H2 P55055 1/20 0.37
▸ NR1H3 Q13133 1/20 0.37
▸ NR1I3 Q14994 1/20 0.37
▸ MME P08473 1/20 0.36
▸ ANPEP P15144 1/20 0.36
▸ SYK P43405 1/20 0.36
▸ CTSK P43235 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122488 0.91 ALDH1A1 (0.42) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL20122481 0.90 CTSK (0.38) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL20122583 0.90 MME (0.36) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL20122394 0.89 KMT2A (0.42) PPARACYP2D6MMEANPEPSYK
SCHEMBL20122551 0.84 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19POLB
SCHEMBL20122545 0.83 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19
SCHEMBL20122444 0.83 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19
SCHEMBL20122592 0.82 CYP1A2 (0.32) CYP1A2CYP2C9CYP2C19
SCHEMBL20122516 0.81 ADRB2 (0.41) PPARACYP2D6IDO1PPARG
SCHEMBL20122556 0.81 ADRB2 (0.39) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback